[
  {
    "ts": null,
    "headline": "Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal",
    "summary": "Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for investors. Click for my SGMO stock update.",
    "url": "https://finnhub.io/api/news?id=6f98aa3397cc409f6c1bf3034d53536a90ac0b780c700cf099537c7b7d92efa8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743778657,
      "headline": "Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal",
      "id": 133721318,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2200067129/image_2200067129.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for investors. Click for my SGMO stock update.",
      "url": "https://finnhub.io/api/news?id=6f98aa3397cc409f6c1bf3034d53536a90ac0b780c700cf099537c7b7d92efa8"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE) – Jim Cramer Declares: ‘Dead Money – Close the Casket!’",
    "summary": "We recently published a list of Jim Cramer’s Lightning Round: 8 Stocks in Focus. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer discusses. Jim Cramer, host of Mad Money, discussed on Monday how investor sentiment surrounding tech stocks has shifted over […]",
    "url": "https://finnhub.io/api/news?id=ff64428c5312b8000ed473e692926b2778ba36518c47d0778f12864aa3e94413",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743777929,
      "headline": "Pfizer Inc. (PFE) – Jim Cramer Declares: ‘Dead Money – Close the Casket!’",
      "id": 133719505,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published a list of Jim Cramer’s Lightning Round: 8 Stocks in Focus. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer discusses. Jim Cramer, host of Mad Money, discussed on Monday how investor sentiment surrounding tech stocks has shifted over […]",
      "url": "https://finnhub.io/api/news?id=ff64428c5312b8000ed473e692926b2778ba36518c47d0778f12864aa3e94413"
    }
  },
  {
    "ts": null,
    "headline": "Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure",
    "summary": "FDA approves SNY's hemophilia therapy, fitusiran, and NVS' rare kidney disease drug, Vanrafia.",
    "url": "https://finnhub.io/api/news?id=28a728a3a7223b24b8087807534b3b83cd8ed7cf96a50c4d09e584a7fd4f6e14",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743774360,
      "headline": "Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure",
      "id": 133719506,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "FDA approves SNY's hemophilia therapy, fitusiran, and NVS' rare kidney disease drug, Vanrafia.",
      "url": "https://finnhub.io/api/news?id=28a728a3a7223b24b8087807534b3b83cd8ed7cf96a50c4d09e584a7fd4f6e14"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights Johnson & Johnson and Pfizer",
    "summary": "Johnson & Johnson and Pfizer are part of the Zacks top Analyst Blog",
    "url": "https://finnhub.io/api/news?id=ae246bbde822dc8bf43585c2f475d490ec308d940338bb60f74d2d50bd966320",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743771840,
      "headline": "The Zacks Analyst Blog Highlights Johnson & Johnson and Pfizer",
      "id": 133719365,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Johnson & Johnson and Pfizer are part of the Zacks top Analyst Blog",
      "url": "https://finnhub.io/api/news?id=ae246bbde822dc8bf43585c2f475d490ec308d940338bb60f74d2d50bd966320"
    }
  },
  {
    "ts": null,
    "headline": "1 Ideal Buy From 23 \"Safer\" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)",
    "summary": "Discover top investment opportunities: Fortune 50 highlights admired companies with strong dividends. Read the full list of stock picks here on Seeking Alpha.",
    "url": "https://finnhub.io/api/news?id=32d998c2fae31ad28c34ec6e39c3013ff821c16b7608d3c185838636ef8c20c7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743771672,
      "headline": "1 Ideal Buy From 23 \"Safer\" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)",
      "id": 133719190,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/172736149/image_172736149.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Discover top investment opportunities: Fortune 50 highlights admired companies with strong dividends. Read the full list of stock picks here on Seeking Alpha.",
      "url": "https://finnhub.io/api/news?id=32d998c2fae31ad28c34ec6e39c3013ff821c16b7608d3c185838636ef8c20c7"
    }
  },
  {
    "ts": null,
    "headline": "Is Pfizer Stock A Sell As HHS Firings, Tariffs Cast A Pall On Pharma?",
    "summary": "Is Pfizer stock a sell now after HHS fired thousands of employees, putting new drug approvals in limbo?",
    "url": "https://finnhub.io/api/news?id=c7523f31ccc856bde2af459ef34b2c41d84abb2950648dd6f7e05aef4804e5d8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743768019,
      "headline": "Is Pfizer Stock A Sell As HHS Firings, Tariffs Cast A Pall On Pharma?",
      "id": 133704834,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Is Pfizer stock a sell now after HHS fired thousands of employees, putting new drug approvals in limbo?",
      "url": "https://finnhub.io/api/news?id=c7523f31ccc856bde2af459ef34b2c41d84abb2950648dd6f7e05aef4804e5d8"
    }
  }
]